Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Director departure
Inv. presentation

Immunovant, Inc. (IMVT) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 8-K Quarterly results
Docs: "Immunovant Reports Financial Results and Provides Corporate Updates for the Quarter Ended June 30, 2023"
08/05/2022 8-K Quarterly results
06/08/2022 8-K Quarterly results
02/04/2022 8-K Quarterly results
11/05/2021 8-K Quarterly results
Docs: "Immunovant Reports Financial Results for the Quarter Ended September 30, 2021 Company Ended the Quarter With Cash of Approximately $559 Million"
08/09/2021 8-K Quarterly results
Docs: "Immunovant Reports Financial Results for the Quarter Ended June 30, 2021"
06/01/2021 8-K Quarterly results
02/16/2021 8-K Quarterly results
11/12/2020 8-K Quarterly results
Docs: "Immunovant Reports Financial Results for the Quarter and Six Months Ended September 30, 2020 Company Ended the Quarter With Cash of Approximately $444 Million"
08/12/2020 8-K Quarterly results
06/29/2020 8-K Quarterly results
02/14/2020 8-K Quarterly results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy